Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors

The sinonasal cavities harbor a wide variety of rare cancer types. Histopathological classification can be challenging, especially for poorly differentiated tumors. Despite advances in surgery and radio-chemotherapy, the 5-year survival rate is still very low. Thus, there is an unmet clinical need f...

Descripció completa

Dades bibliogràfiques

Autors principals:	Eva Villanueva-Fernández, Mario A. Hermsen, Laura Suárez-Fernández, Blanca Vivanco, Alessandro Franchi, Rocío García-Marín, Virginia N. Cabal, Helena Codina-Martínez, Sara Lucila Lorenzo-Guerra, José L. Llorente, Fernando López
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Biomedicines
Matèries:	sinonasal cancer poorly differentiated tumors CD8+ TILs PD-L1 MSI immunotherapy
Accés en línia:	https://www.mdpi.com/2227-9059/10/9/2205
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!